Brain Biotech

Zwingenberg, Germany Founded: 1993 • Age: 33 yrs Listed
Developr of bio-based products and natural compounds for biotechnological solutions

About Brain Biotech

Brain Biotech is a company based in Zwingenberg (Germany) founded in 1993. Brain Biotech has raised $5.38 million across 3 funding rounds from investors including European Union and BMH Hessen. Brain Biotech has completed 2 acquisitions, including AnalytiCon Discovery and Biocatalysts. Brain Biotech operates in a competitive market with competitors including Checkerspot, Fermbox, Bcomp, Industrial Microbes and altM, among others.

  • Headquarter Zwingenberg, Germany
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website brain-biotech.com/en
  • Social LinkedIn X YouTube Threads
  • Legal Name Brain Biotech Ag
Key Metrics

Apps and channels of Brain Biotech

its YouTube channel BRAIN Biotech AG has 114 subscribers and 8 videos.

BRAIN Biotech AG
YouTube 114 subscribers 8 videos Science & Technology
Open channel

Videos from Brain Biotech

The most watched videos on Brain Biotech's YouTube channel, BRAIN Biotech AG (114 subscribers). Click a video to play it here.

Virtueller Rundgang bei BRAIN Biotech am Standort Zwingenberg
1.3K views
BRAIN Biotech AG – Elevator Pitch 2023
473 views
Creating #MicrobialBatteryRecycling
343 views
Michael Schneiders - Capital Markets Day 2024: BRAIN Biotech - Executing Vision 100
223 views

More on BRAIN Biotech AG.

Funding Insights of Brain Biotech

Brain Biotech has successfully raised a total of $5.38M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $310.09 thousand completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.38M
  • Total Rounds 3
  • Last Round Post-IPO β€” $310,090
  • First Round $645,935

    (Jun 2021)

  • Investors Count 2

All 3 funding rounds of Brain Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2024$310,090Post-IPO––
–
May 2024$5.38MUnspecified––
Jun 2021$645,935Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Brain Biotech

Brain Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and BMH Hessen.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Equity and mezzanine capital are provided by BMH Hessen to support Hessian companies.
–bmh-hessen.deWiesbaden, Germany
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Brain Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Brain Biotech

11 people are tracked at Brain Biotech (8 in leadership, 3 in team).

NameRoleGroup
Jurgen Eck
CEOLeadership
Michael Schneiders
Chief Financial OfficerLeadership
Aryan Moelker
Chief Executive OfficerLeadership
Erik de Vries
Senior Business Development Director EnzymesLeadership
Natalie Schweigert
Managing Associate Corporate Services & AdministrationLeadership
Ute Dechert
VP Human Resources & ProcessesLeadership
Alexander Pelzer
Vp, Head Of Research And DevelopmentLeadership
Robbert Michael Hoekstra
Head Of Group FinanceLeadership
Gina Dunlevy
Technical Business Development ManagerTeam
Parul Gupta
Research EngineerTeam
Mihály Menyhárt
Finance ManagerTeam
Premium access

Complete people profiles for Brain Biotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Brain Biotech

Brain Biotech has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include AnalytiCon Discovery and Biocatalysts.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Developer of speciality enzymes for food, fragrance, life science, and other industries
biocatalysts.comCardiff, United Kingdom1999Mar 2018β€’β€’β€’β€’
Natural products chemistry is specialized in by AnalytiCon Discovery.
ac-discovery.comPotsdam, Germany2000Jul 2014β€’β€’β€’β€’
Premium access

Complete acquisition details for Brain Biotech

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Brain Biotech

6 dated milestones of Brain Biotech across 31 years, from founding to its latest funding, stage changes and deals.

  1. Founded Brain Biotech is founded.
  2. Acquisition Acquires AnalytiCon Discovery.
  3. IPO Lists on the stock exchange (IPO).
  4. Acquisition Acquires Biocatalysts.
  5. Funding First funding round of $646K.
  6. Funding Latest funding round, Post-IPO, of $310K.

Competitors of Brain Biotech

Brain Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Checkerspot, Fermbox, Bcomp, Industrial Microbes and altM, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
checkerspot.com2016Oakland, United States$109M–
High-performance materials are developed using synthetic biology for diverse applications.
fermbox.bio2022Bengaluru, India$2.6M18
Alternative animal products are developed via microbial precision fermentation.
bcomp.com2003Fribourg, Switzerland$74.39M–
Sustainable biomaterials for lightweighting in automotive and aerospace are provided.
imicrobes.com2014Emeryville, United States$10.5M12
Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals
altm.bio2022Bengaluru, India$3.5M19
Engineering agri-waste into purpose
bloombiorenewables.com2017Fribourg, Switzerland$19.7M–
Sustainable biopolymers are developed from biomass for industrial uses.
carbios.com2011Ennezat, France––
Enzymatic recycling processes for polyethylene terephthalate are developed and provided.
planetarygroup.ch2022Geneva, Switzerland$11.3M–
Bio-processing, downstream, and formulation services are provided for food manufacturing.
4dmedicine.co.uk2018Birmingham, United Kingdom$4.39M–
Company specializes in research, development, and commercialization of transformative gene therapeutic products for serious medical conditions
Premium access

Detailed competitors of Brain Biotech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Brain Biotech

Websites that share an audience with Brain Biotech (brain-biotech.com).

Similar websites

Websites whose visitors overlap most with Brain Biotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
sharedeals.de
sharedeals.de
100%
–#196,435–
brain-biotech-group.com
brain-biotech-group.com
41%
–––

Latest news on Brain Biotech

Premium access

Complete news archive for Brain Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Brain Biotech

10 companies that operate in the same segment as Brain Biotech (Chemicals Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Microbe-based plant protection products and yield optimization services are provided.
2013Boston, Massachusetts, United StatesUSD 1.4 B––
Plant-based biopesticides are developed for agricultural applications by Terramera.
2010Vancouver, British Columbia, CanadaUSD 64.94 MUSD 3.42 M16
Conductive nanocoatings are delivered via atomic layer deposition technology.
2013Boulder, Colorado, United StatesUSD 202.75 M––
Sustainable bio-based chemicals are manufactured using a proprietary platform.
2016Houston, Texas, United StatesUSD 686.05 M––
Biological insecticides and pesticides are developed from spider peptides.
2001Kalamazoo, Michigan, United StatesUSD 286.68 M––
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
2010Berkeley, California, United StatesUSD 618.08 M––
Instruments and software for color calibration are developed by Datacolor.
1970Lawrenceville, United States–USD 781.59 K20
Green acids are produced from microbes via synthetic biology.
2010Emeryville, California, United StatesUSD 51.77 M––
Phytochemicals are developed using microbial fermentation processes.
2011Cambridge, Massachusetts, United StatesUSD 115.93 M––
Waste carbon is treated via a bio-processing platform.
2005Skokie, Illinois, United StatesUSD 339.3 MUSD 55.84 M384
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Brain Biotech

Brain Biotech was founded in 1993 and raised its 1st funding round 28 years after it was founded.

Brain Biotech is headquartered in Zwingenberg, Germany. It is registered at Zwingenberg, Hesse, Germany.

Jurgen Eck is the current CEO of Brain Biotech.

Brain Biotech is a funded company, having raised a total of $5.38M across 3 funding rounds to date. The company's 1st funding round was a Grant of $645.94K, raised on Jun 2021.

Developr of bio-based products and natural compounds for biotechnological solutions. It provides users with a platform that offers a wide range of biobased products and solutions for various industries, including feed, food, health, and chemicals, as well as environmental applications. The company also provides high throughput isolation of biological products, compound discovery, product development, gene and protein engineering, data analytics, bioinformatics, process development, and process optimization among others.

Brain Biotech's top competitors include Checkerspot, Bloom Biorenewables and Industrial Microbes.

Brain Biotech has made 2 acquisitions, including AnalytiCon Discovery, and Biocatalysts.

Brain Biotech has 2 investors. Key investors include European Union, and BMH Hessen.

Brain Biotech operates through Brain Biotech Ag.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available